# Vancomycin in Primary Sclerosing Cholangitis in Italy

> **NCT05876182** · PHASE2 · RECRUITING · sponsor: **University of Milano Bicocca** · enrollment: 84 (estimated)

## Conditions studied

- Primary Sclerosing Cholangitis
- Liver and Intrahepatic Bile Duct Disorder
- IBD

## Interventions

- **DRUG:** Oral Vancomycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05876182
- **Lead sponsor:** University of Milano Bicocca
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-15
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05876182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05876182, "Vancomycin in Primary Sclerosing Cholangitis in Italy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05876182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*